SLC2A2 and diabetes mellitus: STZ is a glucose analog that selectively accumulates in pancreatic β‐cells via low‐affinity glucose transporter 2 (GLUT2), leading to cytotoxic effects and commonly used to induce experimental diabetes in rats (Jain et al., 2016; Lenzen, 2008).